Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Cell Death & Disease|February 18, 2025
CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemiaLisa Scheiblecker, Thorsten Klampfl, Eszter Doma, et al.Haematologica|March 4, 2017
Cdk6 contributes to cytoskeletal stability in erythroid cellsIris Z Uras, Ruth M Scheicher, Karoline Kollmann, et al.Blood|July 28, 2021
A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cellsSebastian Kollmann, Reinhard Grausenburger, Thorsten Klampfl, et al.Blood|January 13, 2019
CDK6 coordinates JAK2 V617F mutant MPN via NF-κB and apoptotic networksIris Z Uras, Barbara Maurer, Harini Nivarthi, et al.Hemasphere|May 14, 2026
CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatmentBrian Ringhofer, Wolfram Polzer, Michaela Prchal-Murphy, et al.Blood|April 29, 2024
Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cellsIsabella M Mayer, Eszter Doma, Thorsten Klampfl, et al.Science Advances|August 27, 2025
Mitochondrial ROS drive foam cell formation via STAT5 signaling in atherosclerosisLaura Boccuni, Frieda Marka, Manuel Salzmann, et al.Cancer Cell|August 17, 2013
A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesisKaroline Kollmann, Gerwin Heller, Christine Schneckenleithner, et al.Hemasphere|February 24, 2021
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open QuestionsPeter Valent, Alberto Orfao, Stefan Kubicek, et al.Cancer Discovery|June 15, 2018
CDK6 Antagonizes p53-Induced Responses during TumorigenesisFlorian Bellutti, Anca-Sarmiza Tigan, Sofie Nebenfuehr, et al.Pageof 4